Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Tesla, Inc. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while Tesla, Inc. trades at $361.16 (market cap $1.48T). The key difference: Tesla, Inc. is far larger — about 47.6× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| GEHC | TSLA | |
|---|---|---|
Market Cap | $31.07B | $1.48T |
Volume | 3,443,020 | 18,314,332 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $489.88 |
52-Week Low | $59.48 | $298.16 |
Enterprise Value | $39.53B | $1.45T |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 88 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Tesla (TSLA) trades at $375.20, down 0.75% on the day, amid mixed technical signals with a bullish moving average trend but neutral oscillators. The stock faces fundamental headwinds with a high P/E ratio of 347.44 and declining profit margins, though it has beaten earnings estimates in two of the last three quarters. Recent news highlights regulatory approval for its driver-assistance software in Europe and a strategic pivot toward robotics and AI.
The outlook remains bifurcated: long-term growth potential in autonomy and energy storage offers upside, but near-term risks include intense EV competition, earnings volatility, and rich valuations. Analyst consensus is a Buy with a $441.36 price target, yet investor sentiment is cautious due to delivery misses and macroeconomic pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
